Spoken Alpha · Executive

Kevin S Boyle Sr

SVP, CLO, GC & Corp SecretaryVVXV2X, Inc.

In our data from Mar 4, 2024

Tracked across 5 earnings calls in our data since 2021.

Role timeline

VVXV2X, Inc.
SVP, CLO, GC & Corp Secretary
Mar 4, 2024 – Mar 8, 2024 · source: edgar_form4
VVXV2X, Inc.
CLO, GC & Secretary
Mar 4, 2023 – Nov 9, 2023 · source: edgar_form4
TCRTAlaunos Therapeutics, Inc.
Chief Executive Officer
Aug 30, 2021 – Sep 1, 2023 · source: edgar_form4
VVXV2X, Inc.
SVP, CLO & General Counsel
Oct 15, 2018 – May 16, 2022 · source: edgar_form4

Research tier

See how this executive's language deviates from their own baseline

Sign in to view the per-call Behavioral Lean, the language-deviation timeline, and the novel forward-guidance phrases flagged across this executive's earnings calls — each scored against their own prior-call history.

Sign in to view Request research access

Call appearances in our data

5 calls

TCRTQ1 FY2023May 10, 2023

Alaunos Therapeutics, Inc.

TCRTQ2 FY2022Aug 15, 2022

Alaunos Therapeutics, Inc.

TCRTQ1 FY2022May 16, 2022

Alaunos Therapeutics, Inc.

TCRTQ4 FY2021Mar 30, 2022

Alaunos Therapeutics, Inc.

TCRTQ3 FY2021Nov 8, 2021

Alaunos Therapeutics, Inc.